Oberweis Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Oberweis Asset Management's LMAT Position: Q2 2026 in Review
Oberweis Asset Management increased its LeMaitre Vascular (LMAT) stake by 6.7% in Q2 2026, buying an estimated $1.02M and bringing the position to 158,502 shares worth $15.2M. The position accounts for 0.31% of the portfolio, ranked #112.
Oberweis Asset Management first reported a position in LMAT in Q3 2022 and has held it in 16 quarters since. The position peaked at $16.2M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Oberweis Asset Management held 158,502 shares of LeMaitre Vascular worth $15.2M as of Q2 2026.
- Oberweis Asset Management bought 9,901 LeMaitre Vascular shares in Q2 2026, an estimated $1.02M.
- LeMaitre Vascular made up 0.31% of Oberweis Asset Management's portfolio in Q2 2026, its #112 holding.
- Oberweis Asset Management first reported a position in LeMaitre Vascular in Q3 2022 and has held it in 16 quarters since.
- Oberweis Asset Management's LeMaitre Vascular position peaked at $16.2M in Q1 2026.
- 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.